Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google
ENTITY
SMARTSCORE: 3.8/5
Genscript Biotech (1548 HK)
Watchlist
Contact IR
76
Analysis
Health Care
•
Hong Kong
Genscript Biotech Corp is biotech service company. The Company provides life science services and products and pre-clinical drug development services.
more
Watchlist
Contact IR
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Sichuan Kelun-Biotech Biopharm
•
04 Jun 2025 13:51
Kelun-Biotech Placement - Recent Run-Up Makes Its Tricky
Kelun-Biotech Biopharmaceutical Co (Kelun) is looking to raise up to US$200m from a primary placement. In this note, we will talk about the...
Akshat Shah
Follow
278 Views
Share
bullish
•
Genscript Biotech
•
13 Nov 2024 05:10
StubWorld: Hanwha Corp; Genscript Biotech/Legend Biotech
Hanwha Corp appears attractive here. The pushback is that HC is thinly traded. And Genscript’s deconsolidation has minimal impact on financials...
David Blennerhassett
Follow
345 Views
Share
bullish
•
Genscript Biotech
•
25 Jul 2024 08:04
StubWorld: Legend (LEGN US) Offer Or Not, Genscript (1548 HK) Is Attractive
Genscript appears attractive - not just Legend's product pipeline and strong partnerships; but also Genscript's stub ops have been performing well....
David Blennerhassett
Follow
424 Views
Share
bearish
•
Genscript Biotech
•
09 Jun 2024 08:00
China Healthcare Weekly (Jun.9) - New Akeso-Summit Deal, Jacobio Is a Good Bet, Genscript's Trouble
The new Akeso-Summit deal may pave the way for MNC to acquire Summit.Jacobio is a good target for potential M&A/license deal.Genscript faces US...
Xinyao (Criss) Wang
Follow
588 Views
Share
bullish
•
Thematic (Sector/Industry)
•
20 Jul 2022 01:03
2022H2 China Healthcare Investment Strategy and Top Picks
We analyze the investment strategy,top picks and logic in CXO,pharmaceuticals and medical device industry.As a “defensive sector”,China healthcare...
Xinyao (Criss) Wang
Follow
481 Views
Share
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.3
x